Eli, Montreal-based healthcare technology company committed to enhancing women’s lifelong health through saliva-based hormone testing, announced today that it has raised 5 million CAD in new capital to drive its next phase of growth.

 

“Hormones have an enormous impact on women’s health. They are at the root of many conditions, transitions, and symptoms from puberty to menopause. Yet they remain a black box. We are unlocking that box and giving women access to their hormone data daily,” said Marina Pavlovic Rivas, CEO and Co-founder of Eli. “With Eli, women have personalized data at their fingertips to make informed decisions and own their overall health.”

 

Read the official press release